Change of Company Name

RNS Number:8322D
BioProgress PLC
13 September 2007


For Immediate Release                                          13 September 2007

                                BioProgress plc


       BioProgress plc completes name change to Meldex International Plc


London, UK, 13 September 2007: BioProgress Plc ('BioProgress' or the 'Company')
(AIM: BPRG), the specialty pharma and healthcare company, is pleased to announce
that at its EGM held earlier today, the resolution to change the Company's name
from BioProgress Plc to Meldex International Plc was duly passed.

The Company will trade trade under the ticker MDX on the AIM market with effect
from 14 September 2007.



For further information:

BioProgress Plc                                   + 44 (0) 20 7098 9881
Richard Trevillion, CEO
Steve Martin, CDO
Hiral Patel, CFO

Buchanan Communications                           + 44 (0) 20 7466 5000
Rebecca Skye Dietrich
Mark Court


About BioProgress

BioProgress plc is an innovative specialty pharmaceutical and healthcare
business based around its platform technologies in polymer and film systems.
Listed on London's AIM in May 2003, The company has over 80 patents granted or
in application within 24 patent families and has product development agreements
and strategic alliances with several global companies. As a virtually integrated
business, BioProgress has acquired sales and marketing resources within Europe
and the US as a launch mechanism for its own pharmaceutical products. The
business continues to develop innovative delivery mechanisms using its XGELTM
polymer technology. For further information please go to www.bioprogress.com




                      This information is provided by RNS
            The company news service from the London Stock Exchange

END
CANMGGMLVFMGNZM